PACTR201111000338157已完成未知
Early Goal Directed Therapy for adult meningitis in Malawi
iverpool School of Tropical Medicine0 个研究点目标入组 200 人开始时间: 2011年11月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 Year(s) 至 100 Year(s)（—）
- 性别
- All
入选标准
- •Primary inclusion criteria:
- •Fever plus one of
- •Secondary inclusion criteria:
- •CSF white cell count >50 cells per mm2, irrespective of HIV status, or visible bacteria in the counting chamber or on Gram's stain
排除标准
- •Primary exclusion criteria:
- •Known terminal illness
- •Cerebral malaria
- •Head trauma
- •Secondary exclusion criteria
- •CSF culture stain or antigen positive for an organim known to cause fungal or mycobacterial menignitis
- •CSF WCC <50% neutrophils
研究者
相似试验
已完成
不适用
Clinical care Bundles for Adult Meningitis in MalawiISRCTN96218197iverpool School of Tropical Medicine (UK)200
进行中（未招募）
1 期
Meningococcal B Booster Vaccine in Young PeopleMeningococcus group B disease, which can cause a variety of symptoms. The most serious of these are meningitis, and septicaemia (also known as blood poisoning).EUCTR2017-004732-11-GBniversity of Oxford117
已完成
不适用
Meningococcal B Booster Vaccine in Young PeopleSpecialty: Infection, Primary sub-specialty: VaccinesUKCRC code/ Disease: Inflammatory and Immune System/ Certain disorders involving the immune mechanismInfections and InfestationsMeningococcal infection, unspecifiedISRCTN16774163niversity of Oxford72
Unknown
不适用
Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and TreatmentMeningoencephalitisNext-Generation SequencingPolymerase Chain ReactionMeningitisEncephalitisNCT04946682Wen-hong Zhang484
已完成
2 期
Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate VaccineInfections, MeningococcalNCT00356369GlaxoSmithKline500